BBP 股价预测及 ETF 分析 - 分红·管理费·持仓·NAV·RSI·MACD

BBP

Virtus Biotech ETF

收盘价 11月10日 4:00 PM ET（韩国 11/11 06:00）

$103.75

-0.78 ▼ -0.75%

11月10日 4:00 PM ET（韩国 11/11 06:00）

$103.75

+0.00 +0.00%

对称三角形阻力线 105.64 支撑线 100.52 维持

AI 绘制的图表形态仅供参考。

详细指标表

Category ⓘ	US Equities - Industry Sector	Expense ⓘ	0.34%	Return% 1Y ⓘ	40.88%	Total Holdings ⓘ	68	Perf Week ⓘ	0.22%	Volume ⓘ	14,913
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$136M	Return% 3Y ⓘ	29.94%	NAV ⓘ	$104.38	Perf Month ⓘ	0.12%	Avg Volume ⓘ	0.01M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	-	Return% 5Y ⓘ	14.45%	52W High ⓘ	-5.72%	Perf Quarter ⓘ	1.8%	Rel Volume ⓘ	1.19
Active/Passive ⓘ	Passive	Div Gr. 3/5Y ⓘ	-	Return% 10Y ⓘ	13.59%	52W Low ⓘ	40.26%	Perf Half Y ⓘ	17.39%	Prev Close ⓘ	$104.53
IPO ⓘ	2014/12/17	Flows% 1M ⓘ	3.99%	Return% SI ⓘ	12.52%	RSI (14) ⓘ	50.36	Perf YTD ⓘ	29.83%	Price ⓘ	$103.75
Beta ⓘ	0.58	Flows% 3M ⓘ	23.86%	Flows% YTD ⓘ	109.71%	Flows% 1Y ⓘ	156.51%	Perf Year ⓘ	38.31%	Volatility(W/M) ⓘ	2.98% 2.41%
SMA20 ⓘ	0.2%	SMA50 ⓘ	-0.35%	SMA200 ⓘ	11.31%	ATR ⓘ	2.57

ETF 简介

Virtus Biotech ETFBBP | NYSE | 医疗板块查看深度分析

Virtus LifeSci Biotech Products ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

BBP ETF 一览

0.34% 越低越好

$136M 管理资产

68只

上市日期 2014年

运作方式跟踪指数

管理公司 Virtus

主要持仓持有68只

前10大持仓占 基金的20%

均匀分散在众多持仓中。